Skip to content

Drug interactions

Letermovir + Metformin-pioglitazone

Severity: Moderate

Letermovir and Metformin-pioglitazone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir inhibits CYP2C8 and OATP1B1/3, so it may raise pioglitazone exposure, which is metabolized by CYP2C8. This can increase pioglitazone effects such as edema and hypoglycemia when combined with other agents.

What this interaction means in plain words

Letermovir and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Letermovir belongs to Anti Virals; Metformin-pioglitazone belongs to Endocrine.

Evidence level: Moderate

Why it happens

Letermovir inhibition of CYP2C8 and hepatic OATP transporters reduces pioglitazone clearance.

What to do

Monitor blood glucose and for fluid retention during coadministration, and reduce the pioglitazone dose if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Metformin-pioglitazone?

MediHelp rates the interaction as moderate. Letermovir and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letermovir inhibits CYP2C8 and OATP1B1/3, so it may raise pioglitazone exposure, which is metabolized by CYP2C8. This can increase pioglitazone effects such as edema and hypoglycemia when combined with other agents.

How serious is the interaction between Letermovir and Metformin-pioglitazone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and for fluid retention during coadministration, and reduce the pioglitazone dose if needed.

What other medicines interact with Metformin-pioglitazone?

MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in